a decreasing trendp = 0.049
Similarly, piperacillin‐tazobactam resistance demonstrated a decreasing trend over time ( p = 0.049), while meropenem resistance showed variability without a statistically significant trend ( p = 0.470).
Similarly, piperacillin‐tazobactam resistance demonstrated a decreasing trend over time ( p = 0.049), while meropenem resistance showed variability without a statistically significant trend ( p = 0.470).
Patients with pulmonary infection had the highest mortality rate but did not reach statistical significance in univariate analysis (OR: 5.6 (0.9–34.80), p = 0.066) (Figure 2 ).